Regulation & law · 20/09/2002

U.S. Patent Application for Hemorrhaging Treatment Now Available for Licensing

The U.S. Patent and Trademark Office has made available the licensing of a patent application for compositions treating hemorrhaging with activated Factor VIIa and fibrinogen, filed on January 10, 2001, and owned by the U.S. Government, represented by the Secretary of the Army.